The purpose of this study is to investigate the efficacy and safety of dietary supplement GABA in subjects with mild, transient sleep disorder.
The subjects will take GABA or placebo capsule once daily before sleep for 14 days.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Enrollment
60
Kyunghee University Hospital at Gangdong
Seoul, South Korea
Change of total sleep time of polysomnography
total sleep time(minutes)
Time frame: Baseline, Week 2
Change of sleep latency of polysomnography
sleep latency(minutes)
Time frame: Baseline, Week 2
Change of sleep efficiency of polysomnography
sleep efficiency(percent)
Time frame: Baseline, Week 2
Change of NonREM stage3 of polysomnography
NonREM stage3(mintues)
Time frame: Baseline, Week 2
Change of total wake time of polysomnography
total wake time(mintues)
Time frame: Baseline, Week 2
Change of wake after sleep onset of polysomnography
wake after sleep onset(mintues)
Time frame: Baseline, Week 2
Change of Pittsburgh Sleep Quality Index
Change of Pittsburgh Sleep Quality Index(0-21), higher score means worse outcome
Time frame: Baseline, Week 2
Change of Insomnia Severity Index
Change of Insomnia Severity Index(0-28), higher score means worse outcome
Time frame: Baseline, Week 2
Change of Epworth sleepiness scale
Change of Epworth sleepiness scale(0-24), higher score means worse outcome
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Baseline, Week 2
Change of Fatigue Severity Scale
Change of Fatigue Severity Scale(9-63), higher score means worse outcome
Time frame: Baseline, Week 2